 
 
观点聚焦 Investment Focus 
本研究报告由海通国际分销，海通国际是由海通国际研究有限公司，海通证券印度私人有限公司，海通国际株式会社和海通国
际证券集团其他各成员单位的证券研究团队所组成的全球品牌，海通国际证券集团各成员分别在其许可的司法管辖区内从事证
券活动。关于海通国际的分析师证明，重要披露声明和免责声明，请参阅附录。(Please see appendix for English translation of the 
disclaimer) 
 
 
研究报告Research Report 
 
3 Nov 2022 
 
贵州茅台 Kweichow Moutai (600519 CH) 
首次覆盖：茅台酒与系列酒双轮驱动，主动营销拉升直营占比 
Moutai liquor and series liquor double-wheel driven, and active marketing to enhance direct channel sales: Initiation 
首次覆盖优于大市Initiate with OUTPERFORM 
 
评级 
优于大市OUTPERFORM 
现价 
Rmb1,472 
目标价 
Rmb2,048 
MSCI ESG 评级 
B 
义利评级 
BBB- 
来源: MSCI ESG Research LLC, 盟浪. Reproduced by permission; no further distribution 
市值 
Rmb1,849bn / US$254.30bn 
日交易额 (3 个月均值) 
US$840.75mn 
发行股票数目 
1,256mn 
自由流通股 (%) 
38% 
1 年股价最高最低值 
Rmb2,194-Rmb1,350 
注：现价Rmb1,472 为2022 年11 月2 日收盘价 
 
 
资料来源： Factset 
 
 
1mth 
3mth 
12mth 
绝对值 
-21.4% 
-22.1% 
-17.5% 
绝对值（美元） 
-23.3% 
-27.7% 
-27.3% 
相对MSCI China 
20.7% 
21.2% 
33.0% 
 
(Rmb mn) 
Dec-21A 
Dec-22E 
Dec-23E 
Dec-24E 
营业收入 
109,464 
126,526 
144,824 
163,289 
(+/-) 
12% 
16% 
14% 
13% 
净利润 
52,460 
61,651 
71,464 
81,806 
(+/-) 
12% 
18% 
16% 
14% 
全面摊薄EPS 
(Rmb) 
41.76 
49.08 
56.89 
65.12 
毛利率 
91.6% 
91.9% 
92.3% 
92.6% 
净资产收益率 
26.6% 
26.9% 
27.0% 
26.9% 
市盈率 
35 
30 
26 
23 
资料来源：公司信息, HTI 
 
 
(Please see APPENDIX 1 for English summary) 
白酒行业仍处于调整周期，行业去库存将延续到1Q23-
2Q23。需求走弱，疫情反复造成商务、宴请、送礼场景缺失，同
时行业库存略高，22 年行业预期还有10-15%未发货，库存将进一
步上行，增加4Q22 和1Q23 行业压力，体现为酒企主流产品近期
批价不稳有所下行。我们判断白酒行业将在明年1Q-2Q 触底。 
完善价格带布局，茅台酒与系列酒双轮驱动。受限于产能和
提价困境，茅台酒量价齐升动力不足，需要非标酒放量和直营占
比提升支持增长。系列酒增量贡献来自于各价格带战略产品的放
量和产品升级，我们预期22 年茅台1935 销售达到2500 吨(约46
亿)，汉酱作为500-1000 元价格带的战略单品未来可能有资源倾
斜，同时茅台王子酒和迎宾酒持续提价升级和稳健增长。 
“五合营销法”推进主动营销+数字化融合，拉升直营占比，
推动均价和利润率持续上行。i 茅台是2Q22 新增渠道，是新品
推出和直营提升重要渠道之一。目前i 茅台销售和预约申购共9 款
酒类产品， 6 款茅台酒和3 款系列酒。我们预期i 茅台全年收入
120-130 亿元，约占比总体收入10%，贡献较多的产品为虎年生肖
酒(500ml)和茅台1935(500ml)。受益于i 茅台的直营渠道加法，我
们预期全年直营占比在37%，进一步拉升均价和利润率上行。 
茅台酒和系列酒新增产能落地后，预期将缓解产能不足问
题。茅台酒产销缺口(4 年前产量对应当年销量)自2018 年出现并
在2019 年出现最大缺口(短缺比例25%以上)，2021 年该比例下降
到5.5%。目前公司在优质地块上积极扩建，有四个在建项目，我
们预期投产后2025-2026 年基本能解决产能问题。系列酒目前同样
面临产能不足问题，难以支持在各价格带的产品迅速放量，在目
前在建的4.2 万吨系列酒产能落地投产之后，我们预期系列酒产能
不足的问题将得到彻底解决。 
投资建议与盈利预测。我们预期公司2022-2024 年总收入分别为
1265/1448/1633 亿元，净利润分别为617/715/818 亿元。短期股价
下挫较多主要因为：1）茅台及部分优质白酒企业3Q22 业绩低于
预期；2）需求疲软和行业去库存使白酒行业处于调整周期；3）
政务消费预期收紧；4）资金面压力。目前贵州茅台股价对应23 年
25.9X PE，建议低位布局。我们首次覆盖给予贵州茅台“优于大市”
评级，给予23 年36X PE 估值，目标价2048 元，有39%的上行空
间。 
风险提示。白酒行业下行风险，疫情反复影响需求，消费力低于
预期。 
 
 
Yuanyuan Kou 
闻宏伟Hongwei Wen 
yy.kou@htisec.com 
hongwei.wen@htisec.com 
50
75
100
125
150
Price Return
MSCI China
Nov-21
Mar-22
Jul-22
Nov-22
Volume
 
 
3 Nov 2022 
2 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
 
1. 
白酒行业仍处于调整周期，行业去库存将延续到1Q23-2Q23  
回顾调整周期，经济周期和产业政策周期是白酒行业调整的根本原因，库存
周期加大白酒行业的周期性波动。 
复盘过去20 年白酒行业，1999-2002 年受从量税政策影响，销量下滑带动行业增速回
落，产品高端化推动吨价持续提升。2003-2012 年，受益于经济高速增长和人口红
利，行业迎来发展的黄金十年，量价齐升(期间有非典、金融危机等阶段性影响)。
2013-2015 年，受限于三公消费政策的冲击，白酒行业进入深度调整，实现饮用人群
和饮用场景的转换。2016-2020 年，白酒主流消费从政务消费转移到大众消费，人口
红利结束，消费升级推动白酒行业吨价明显提升，是行业增长的主要推动力。2021 年
至今，疫情反复影响消费场景，商务消费和宴席消费萎缩，产品升级短期也受到消费
力走弱的影响。可见，经济周期和产业政策周期是白酒行业调整的根本原因。 
 
图1 贵州茅台收入及白酒周期复盘 
 
资料来源：公司公告，HTI 
 
库存周期一般跟随供需关系错配而波动，但并非造成行业周期性的根本原因，只会加
大白酒行业周期性的波动。如2003-2012 年的白酒行业10 年黄金发展期，价格持续上
行，渠道普遍囤货增加库存。之后三公消费对需求场景造成冲击，供需关系严重错
配，拉长行业自我调节的时间。本轮周期中，白酒企业吸收历史经验，且对批价更为
看中，已加强对库存的管控。然而，需求疲软，且疫情反复造成商务、宴请、送礼场
景缺失，同时行业库存略高，预期22 年行业还有10-15%未发货，库存将进一步上
行，增加4Q22 和1Q23 的行业压力，体现为酒企主流产品近期批价不稳，有所下行。
我们判断白酒行业将在2023 年1Q-2Q 触底，部分公司4Q22 和1Q23 业绩可能低于预
期。因此，我们判断，白酒行业仍处于调整周期，行业去库存将延续到1Q23-2Q23，
之后将逐渐恢复。 
 
 
3 Nov 2022 
3 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
图2 主要白酒企业库存复盘 
 
资料来源：渠道调研、微酒、酒说、HTI 
 
2．完善价格带布局，茅台酒与系列酒双轮驱动 
2.1 受限于产能，2022 年非标茅台酒与茅台1935 是主要增量来源 
2014 年底茅台公司对产品进行了战略性梳理，提出了“做强茅台酒，做大系列酒”，茅
台酒和系列酒双轮驱动的战略体系正式成立。同时，自2017 年开始，集团对内非股
份公司的白酒产品进行清理整合，剥离了习酒等股权。 
茅台酒包括飞天茅台、低度茅台酒和非标茅台酒（年份酒、生肖酒、定制酒和纪念酒
等）。系列酒包括“一曲三茅四酱”，“一曲”即贵州大曲，“三茅”即赖茅、王茅以及华
茅，“四酱”即茅台王子酒、茅台迎宾酒、汉酱酒以及仁酒。2021 年茅台酱香系列酒经
销商大会明确了“品价匹配、层次清晰、梯度合理”的系列酒产品结构， “茅台1935”定
位千元价格带，500-1000 元价格带主打“汉酱”品牌，200-500 元价格带主打“茅台王子
酒”。 
根据2021 年报表披露数据，茅台酒收入935 亿，我们预期高度飞天茅台约为720 亿，
低度飞天体量在30 亿以内，精品酒体量在20 亿以内。2021 年系列酒突破百亿收入体
量达到126 亿，其中茅台王子酒贡献最大体量，约在50 亿左右，汉酱、贵州大曲和
茅台迎宾酒均为超10 亿体量大单品。2022 年系列酒将成为拉动总体收入增长的主要
动力，量价齐升，主要增量贡献来自于茅台1935。 
受限于产能和提价困境，茅台酒量价齐升动力不足，需要非标酒放量和直营占比提升
予以支持。我们预期2022 年非标酒销量增速在15%左右。系列酒增量贡献来自于各价
格带战略产品的放量和产品升级，我们预期22 年茅台1935 销售达到2500 吨(约46
亿)，汉酱作为500-1000 元价格带的战略单品未来可能有资源倾斜，同时茅台王子酒
和迎宾酒持续提价升级。 
 
 
 
 
 
 
 
 
 
 
3 Nov 2022 
4 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
表1 茅台酒产品矩阵 
 
资料来源：公开资料、HTI 
 
表2 系列酒产品矩阵 
 
资料来源：公开资料、HTI 
 
第三轮 
第四轮 
第三轮 
第四轮 
 
 
3 Nov 2022 
5 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
2.2 茅台1935 定位千元价位段，有望成为大单品 
千元价位白酒定义在终端成交价在1000-1500 元的白酒产品，该价位白酒体量不大，
约在700 亿规模，五粮液一家独大，高度老窖1573 位居第二，青花郎位列第三，其
他品牌产品在该价位段积累不深，占比较小。 
千元价位段产品需要较高的品牌门槛和产品基因，同时要有高品质匹配其价位段。短
期可以通过品牌拉动放量，但中长期要做成大单品，需要品牌、品质、渠道力、组织
力等多维度系统化管理能力以支持。 
2022 年年初，为了突破茅台酒的产能瓶颈和弥补价格带缺失，公司发布茅台1935，
其战略定位是茅台系列酒的主力产品，目标打造为大单品。茅台1935 出厂价798 元，
终端供货价 998 元，零售指导价 1188 元，终端成交价1200-1500 元。茅台1935 是由
30-40%的茅台酒基酒和60-70%优质系列酒基酒勾兑而成，品质上介于飞天迎宾和飞天
之间，千元定位合理。上市之初，市场关注度较高，终端价炒作到1800 元以上，近
期价格回归理性，终端价格回落至1200-1500 元。 
我们预期2022 年茅台1935 销量约2500 吨，贡献约46 亿收入增量。我们看好茅台
1935 的品牌背书，千元价格带的战略定位，预期空间较大。短中期需要公司系统化运
营和管理，维持价格体系和渠道利差，持续开拓商务和高端宴席场景，增加目标群体
黏性和复购率。 
 
图3 千元价位段各品牌市占率 
资料来源：公开资料，HTI 
图4 茅台1935 预期收入体量及占比系列酒% 
 
资料来源：HTI 
 
3. “五合营销法”推进主动营销+数字化融合，拉升直营占比，推动均价和利润
率持续上行 
i 茅台是2Q22 新增渠道，是新品推出和直营提升重要渠道之一。目前i 茅台销售和预
约申购共9 款酒类产品， 6 款茅台酒和3 款系列酒。我们预期i 茅台全年收入120-130
亿元，约占比总体收入10% ，贡献较多的产品为虎年生肖酒(500ml) 和茅台
1935(500ml)。受益于i 茅台的直营渠道加法，我们预期全年直营占比在37%，进一步
拉升均价和利润率上行。 
 
3.1 丁雄军时代：“五合营销法”推进主动营销、数字化销售和渠道改革 
2022 年2 月，集团董事长丁雄军在茅台市场工作会上提出“五合营销法”。 
（1）资源整合，统筹全集团酒类产品管理，深耕直营/经销等多种渠道，实施高效精
准的主动营销。公司今年主动发力茅台1935，年初推出产品后，密集的在全国地标性
建筑、交通枢纽、影院等平台投放广告，同时在全国举办千场品鉴会推广产品。我们
 
 
3 Nov 2022 
6 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
预期茅台1935 今年体量在2500 吨左右，明年增量预期较少，公司可能会加大推广
500-1000 元价位段产品，如汉酱品牌，符合系列酒经销商大会提出的“品价匹配、层
次清晰、梯度合理”产品结构。 
（2）数字融合，发力新零售，完善数字营销。i 茅台为新的数字平台渠道带来新增
量，实现从包装生产到消费者的全链路打通，对每瓶酒都能通过对生产、仓储、物
流、销售等关键信息的数字化集成，实现从产品到商品的全过程的溯源。 
（3）文化相合，整合茅台优势文化资源，树立品牌形象。 
（4）品牌聚合，构建“价格匹配、层次清晰、梯度合理”的品牌体系，梳理产品及对
应价位段，对茅台酒、酱香系列酒、集团产品做明确分割，优化产品结构，提升品牌
竞争力。 
（5）管服结合，做营销渠道改革，提高市场管理能力和市场服务能力。 
可以看出，“五合营销法”重点在于加大建设直营渠道，梳理重点产品，使各价格带产
品做大做强。 
3.2 i 茅台数字化平台是新品推出和直营提升重要渠道之一 
目前i 茅台销售和预约申购共9 款酒类产品， 6 款茅台酒和3 款酱香系列酒。6 款茅台
酒为100ml 飞天茅台，43 度飞天茅台，43 度喜宴，茅台虎年生肖酒(500ml 和375ml)，
珍品。3 款酱香系列酒为茅台1935，茅台王子酒，茅台迎宾酒。 
根据茅台3Q 报表，i 茅台前九个月已经贡献84.6 亿税后收入，占比总体收入10%；其
中3Q 贡献约40 亿税后收入，占比总体收入14%。i 茅台全年收入贡献预期120-130 亿
元，约占比全年收入10% ，贡献较多的产品为虎年生肖酒(500ml) 和茅台
1935(500ml)。茅台曾尝试多次线上或电商销售方式，成效一般。i 茅台基于其数字化
集成能力和全链路打通的优势，有望成为重要的直营渠道之一。目前i 茅台已覆盖31
个省级行政区，线下取货服务门店近2000 家，服务约600 万人，我们预期其销售量
会进一步提升。 
受益于i 茅台的直营渠道加法，直营渠道表现两眼， 9M22 直营增长117%，贡献37%
的白酒销售收入。 
图5 千元价位段各品牌市占率 
资料来源：公司公告、HTI 
图6 茅台1935 预期收入体量及占比系列酒% 
资料来源：公司公告、HTI 
 
3.3 直营渠道占比提升拉动吨价和GPM 的提升 
茅台增速放缓的原因之一是吨价提升受限，主要产品飞天茅台系列(53 度和43 度)难以
自由提价。直营占比提升或批发业务非标酒占比提升，可以拉动平均吨酒价和GPM上
行。 
 
 
3 Nov 2022 
7 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
图7 茅台酒和系列酒ASP yoy 
 
资料来源：公司公告、HTI 
图8 直营GPM 提升和直营占比上行拉动整体GPM 扩张 
 
资料来源：公司公告、HTI 
i 茅台销售占比提升能够有效提升吨价。9 款产品价格带覆盖全面，从218 元到4599
元，更好适应广大消费者需求。对比i 茅台上线产品销售价格和其出厂价，扣除经销
商每500ml 要100 元配送费，利润依旧有明显提升，尤其出货量较大的虎年生肖茅台
和茅台1935，单瓶额外利润有400 元和300 元。i 茅台特有产品100ml 飞天小酒售价
为399 元，扣除20 元配送费用后，对应实际每500ml 出厂价为1895 元，几乎为500ml 
经典飞天的2 倍。 
表3 i 茅台直营产品额外利润水平 
 
资料来源：i 茅台、公开资料、HTI 
 
4. 茅台酒和系列酒新增产能落地后，预期将解决产能不足问题  
4.1 茅台酒产能缺口在2019 年达到最大(短缺比例在25%以上)，系列酒产能在
2017-2019 年缺口较大(短缺比例在30%左右) 
茅台增速放缓的另一原因是产能受限。将茅台酒和系列酒拆分来看，鉴于茅台酒基酒
酿成后仍需要经过长时间贮存才能勾调上市，一般而言当年生产的基酒对应4 年后的
成品酒。我们按照80%比例测算4 年前生产的茅台基酒转换为茅台成品酒，对照当年
销售量，茅台从2018 年开始出现短缺，并在2019 年出现最大缺口(短缺比例在25%以
上)，2021 年该比例下降到5.5%。 
 
 
3 Nov 2022 
8 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
图9 茅台酒产能缺口在2018 年出现并在2019 年达到最大 
 
资料来源：公司公告、HTI 
 
假设酱香系列酒用的是1 年前所生产基酒产能生产，系列酒在2017-2019 年产能缺口
较大，短缺比例达到30%左右，之后有所缓解，2021 年回升到17%。 
图10 系列酒在2017-2019 年产能缺口较大 
 
资料来源：公司公告、HTI 
 
4.2 茅台酒和系列酒新增产能落地后，预期将解决产能不足问题 
公司在优质地块上积极扩建和新建产能，茅台酒目前有四个在建项目，同时还在积极
推进技改。据公司表述，茅台酒扩产项目基本落地，2025 年将满负荷释放产能。我们
预期产能全部投产后，在2025-2026 年供需基本达到平衡。 
 
 
3 Nov 2022 
9 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
表4 茅台酒产能建设(包括在建产能) 
 
资料来源：公司公告、HTI 
 
公司要实现茅台酒与系列酒双轮驱动，产能是对“做大系列酒”的基本保障，公司同样
在积极扩建系列酒产能，目前有2 个大产量在建项目。我们预期2022-2025 年系列酒
销量将维持高单位数的增长，当前在建的4.2 万吨系列酒产能落地投产之后，酱香系
列酒当年产能不足的问题将得到彻底解决。 
 
表5 系列酒产能建设(包括在建产能) 
 
资料来源：公司公告、HTI 
 
5. 盈利预测和投资建议 
根据仁怀市十四五规划，茅台集团2025 年营收目标为2000 亿元，2022 年习酒剥离出
茅台集团(2022 年收入体量在180 亿左右)，股份公司有一定压力。我们预期公司2022-
2025
年总收入分别为
1265/1448/1633/1833
亿元，同比增长
15.6%/14.5%/12.8%/12.3%。 
我们预期茅台酒2022-2025 年收入分别为1056/1202/1355/1521 亿元，同比增长
13.0%/13.9%/12.7%/12.3%，其中茅台酒销量分别增长5%/5%/6%/6%，茅台酒均价分别
提升7.6%/8.5%/6.3%/5.9%。销量方面，随着产能释放，茅台酒短缺情况得到一定缓
解。我们预期茅台酒直营销量占比持续上升，在
2022-2025
年贡献
37%/43.3%/46.3%/48.8%茅台酒收入。均价持续提升主要受益于直营占比上升，以及
经销商业务中非标酒的比例持续提升，均价没有计入未来飞天茅台的直接提价因素。 
 
 
3 Nov 2022 
10 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
图11 茅台酒收入/销量/均价预期 
 
资料来源：公司公告、HTI 
 
我们预期酱香系列酒2022-2025 年收入分别为174/208/238/270 亿元，同比增长
38.0%/19.9%/14.5%/13.4%，其中系列酒销量分别增长20%/11%/9%/8%，系列酒均价
分别提升15%/8%/5%/5%。销量方面，2022 年最大增量来自于茅台1935(2500 吨/47 亿
收入)；预期汉酱在2023 年可能会有资源倾斜增速更快，因为公司第二要重点打造的
系列酒是500-1000 元价格带的产品；其他产品如茅台王子酒和茅台迎宾酒均有产品系
列梳理和升级，如金王子和紫迎宾。均价方面，随着茅台1935 和汉酱占比提升，以
及其他产品不断升级提价，均价会持续上行。 
图12 系列酒收入/销量/均价预期 
 
资料来源：公司公告， HTI 
 
我们预期茅台酒和酱香系列酒的毛利率均持续上行。茅台酒毛利率受益于直营渠道贡
献增加和批发渠道非标酒贡献上升，酱香酒毛利率受益于各价位段产品升级、高端系
列酒占比提升、和直营渠道销售占比增加。 
 
 
3 Nov 2022 
11 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
图13 预期茅台酒和系列酒毛利率均持续上行 
 
资料来源：公司公告， HTI 
 
我们预期茅台2022-2025 年净利润分别为617/715/818/929 亿元，同比增长
17.5%/15.9%/14.5%/13.5%,净利率分别为48.7%/49.3%/50.1%/50.7%。 
图14 预期净利率均持续上行 
 
资料来源：公司公告， HTI 
 
我们预期公司2022-2024 年总收入分别为1265/1448/1633 亿元，净利润分别为
617/715/818 亿元，对应22-24 年PE 为30.0X/25.9X/22.6X。短期股价下挫较多主要因
为：1）茅台及部分优质白酒企业3Q22 业绩低于预期；2）需求疲软和行业去库存使
白酒行业处于调整周期；3）政务消费预期收紧；4）资金面压力。我们判断白酒行业
将在明年1Q-2Q 触底，部分公司4Q22 和1Q23 业绩可能低于预期。目前贵州茅台股
价对应23 年25.9X，建议低位布局。我们首次覆盖给予贵州茅台“优于大市”评级，给
予23 年36X PE 估值，目标价2048 元，有39%的上行空间。 
 
 
 
 
3 Nov 2022 
12 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
表6 可比上市公司估值预测 
资料来源：wind， HTI 
注：收盘价为2022 年11 月2 日数据，盈利预测来源于Wind 一致预期 
 
 
 
 
 
6. 风险提示 
白酒行业下行风险，疫情反复影响需求，消费力低于预期。 
 
   
 
 
 
 
 
 
3 Nov 2022 
13 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
Table 1 
财务报表分析和预测 
 
 
 
 
资料来源：HTI 
 
 
 
 
3 Nov 2022 
14 
贵州茅台 (600519 CH) 
首次覆盖优于大市 
APPENDIX 1 
Summary 
White liquor industry is still in the downward cycle and the industry inventory will continue to climb up till 1Q23-2Q23. Due to the 
weak demand, missing scenarios of business/banquets gathering as a result of the epidemic, slight high industry inventory, and 
unshipped 10-15% white liquor 2022 quota, we see increasing industry pressure in 4Q22 and 1Q23, as reflected in the recent 
instability of the mainstream products of major white liquor names. We expect that the liquor industry will bottom out in 1Q-2Q 
next year, and some companies may deliver lower than expected performance in 4Q22 and 1Q23. 
 
Moutai liquor and series liquor are two-wheel drivers, supported by comprehensive layout of products in different price bands. 
Limited by production capacity and policies pressure on price hike, the company growth is driven by Moutai liquor, non-standard 
Moutai liquor, and direct channel sales. We expect Moutai 1935 sales to reach 2,500 tons (about 4.6 billion) in 2022, and Hanjiao, 
as a strategic product in the 500-1,000RMB price band, may deliver more sales in the future. At the meantime, Moutai Prince 
liquor and Yingbin liquor will continue to grow steadily. 
 
The "five-combined marketing method" indicates active marketing and digital integration, boosting direct sales, and driving 
average price and profitability. iMoutai platform is a new channel initiated in 2Q22, and is one of the important channels for new 
product launch and direct sales. Currently, iMoutai launched 9 alcoholic products, including 6 Moutai liquor and 3 series liquor. 
We expect that iMoutai will deliver 12-13bn RMB revenue in 2022, accounting for around 10% of overall revenue, with more 
contributing from the Tiger Zodiac Moutai liquor (500ml) and Moutai 1935 (500ml). Benefiting from iMoutai's direct sales, we 
expect that the full-year direct sales will account for 37% of total revenue, with higher average prices and margins upward. 
 
The shortage of production capacity is expected to be addressed when the expansion capacity of Moutai liquor and series liquor 
is landed. The gap between Moutai liquor production and sales (produced 4 years ago vs. current sales) had emerged since 2018 
and reached the largest gap in 2019 (shortage ratio above 25%), and then the shortage ratio dropped to 5.5% in 2021. The company 
is actively expanding on premium sites with four projects under construction, which we expect to basically solve the capacity 
problem in 2025-2026 when they go into production. Series liquor is facing the same issue of insufficient capacity to support the 
strong sales in various price zones. After the 42,000-ton series liquor capacity, currently under construction, is put into operation, 
we expect the problem of insufficient capacity for series liquor to be completely solved. 
 
We expect the company's total revenue to be 126.5/144.8/163.3 billion RMB and net profit to be 61.7/71.5/81.8 billion RMB from 
2022-2024, respectively. The reasons of short-term stock price correction: 1) lower than expected 3Q22 earning result of Moutai 
and some high-quality liquor companies; 2) weak demand and industry de-stocking cycle; 3) government consumption is expected 
to tighten; 4) funds outflow pressure. The current stock price of Guizhou Moutai is trading at 24X PE of 2023’s earning, or 1.6X PEG 
of 2023’s earning. We initiate Kweichow Moutai with OUTPERFORM, assigning 36X PE valuation of 2023’s earning with target price 
of 2048 RMB and 39% upside. 
 
Risk: Downside cycle of the liquor industry, weak demand due to epidemics, and lower than expected consumption power
 
 
 
 
15 
 
附录APPENDIX 
重要信息披露 
本研究报告由海通国际分销，海通国际是由海通国际研究有限公司(HTIRL)，Haitong Securities India Private Limited (HSIPL)，Haitong International Japan K.K. (HTIJKK)和海通国际证券有限公
司(HTISCL)的证券研究团队所组成的全球品牌，海通国际证券集团(HTISG)各成员分别在其许可的司法管辖区内从事证券活动。 
IMPORTANT DISCLOSURES 
This research report is distributed by Haitong International, a global brand name for the equity research teams of Haitong International Research Limited (“HTIRL”), Haitong Securities India Private 
Limited (“HSIPL”), Haitong International Japan K.K. (“HTIJKK”), Haitong International Securities Company Limited (“HTISCL”), and any other members within the Haitong International Securities Group 
of Companies (“HTISG”), each authorized to engage in securities activities in its respective jurisdiction. 
HTIRL 分析师认证Analyst Certification: 
我， Kou Yuanyuan，在此保证（i）本研究报告中的意见准确反映了我们对本研究中提及的任何或所有目标公司或上市公司的个人观点，并且（ii）我的报酬中没有任何部分与本研究报
告中表达的具体建议或观点直接或间接相关；及就此报告中所讨论目标公司的证券，我们（包括我们的家属）在其中均不持有任何财务利益。I, Kou Yuanyuan, certify that (i) the views 
expressed in this research report accurately reflect my personal views about any or all of the subject companies or issuers referred to in this research and (ii) no part of my compensation was, is or 
will be directly or indirectly related to the specific recommendations or views expressed in this research report; and that I (including members of my household) have no financial interest in the 
security or securities of the subject companies discussed. 
我， 闻宏伟，在此保证（i）本研究报告中的意见准确反映了我们对本研究中提及的任何或所有目标公司或上市公司的个人观点，并且（ii）我的报酬中没有任何部分与本研究报告中表
达的具体建议或观点直接或间接相关；及就此报告中所讨论目标公司的证券，我们（包括我们的家属）在其中均不持有任何财务利益。I, Hongwei Wen, certify that (i) the views expressed 
in this research report accurately reflect my personal views about any or all of the subject companies or issuers referred to in this research and (ii) no part of my compensation was, is or will be 
directly or indirectly related to the specific recommendations or views expressed in this research report; and that I (including members of my household) have no financial interest in the security or 
securities of the subject companies discussed. 
 
利益冲突披露Conflict of Interest Disclosures 
海通国际及其某些关联公司可从事投资银行业务和/或对本研究中的特定股票或公司进行做市或持有自营头寸。就本研究报告而言，以下是有关该等关系的披露事项（以下披露不能保
证及时无遗漏，如需了解及时全面信息，请发邮件至ERD-Disclosure@htisec.com） 
HTI and some of its affiliates may engage in investment banking and / or serve as a market maker or hold proprietary trading positions of certain stocks or companies in this research report. As far 
as this research report is concerned, the following are the disclosure matters related to such relationship (As the following disclosure does not ensure timeliness and completeness, please send an 
email to ERD-Disclosure@htisec.com if timely and comprehensive information is needed). 
 
贵州茅台酒厂集团啤酒有限责任公司,茅台建信（贵州）投资基金管理有限公司－贵州茅台建信食品投资管理中心（有限合伙） 及 000596.CH 目前或过去12 个月内是海通的客户。海通
向客户提供非投资银行业务的证券相关业务服务。 
贵州茅台酒厂集团啤酒有限责任公司,茅台建信（贵州）投资基金管理有限公司－贵州茅台建信食品投资管理中心（有限合伙） and 000596.CH are/were a client of Haitong currently or 
within the past 12 months. The client has been provided for non-investment-banking securities-related services. 
 
评级定义（从2020 年7 月1 日开始执行）： 
海通国际（以下简称“HTI”）采用相对评级系统来为投资者推荐我们覆盖的公
司：优于大市、中性或弱于大市。投资者应仔细阅读HTI 的评级定义。并且HTI
发布分析师观点的完整信息，投资者应仔细阅读全文而非仅看评级。在任何情
况下，分析师的评级和研究都不能作为投资建议。投资者的买卖股票的决策应
基于各自情况（比如投资者的现有持仓）以及其他因素。 
分析师股票评级 
优于大市，未来12-18 个月内预期相对基准指数涨幅在10%以上，基准定义如
下 
中性，未来12-18 个月内预期相对基准指数变化不大，基准定义如下。根据
FINRA/NYSE 的评级分布规则，我们会将中性评级划入持有这一类别。 
弱于大市，未来12-18 个月内预期相对基准指数跌幅在10%以上，基准定义如
下 
各地股票基准指数：日本 – TOPIX, 韩国 – KOSPI, 台湾 – TAIEX, 印度 – Nifty100, 美
国 – SP500; 其他所有中国概念股 – MSCI China. 
Ratings Definitions (from 1 Jul 2020):  
Haitong International uses a relative rating system using Outperform, 
Neutral, or Underperform for recommending the stocks we cover to 
investors. Investors should carefully read the definitions of all ratings used 
in Haitong International Research. In addition, since Haitong International 
Research contains more complete information concerning the analyst's 
views, investors should carefully read Haitong International Research, in its 
评级分布Rating Distribution 
 
 
 
 
 
16 
entirety, and not infer the contents from the rating alone. In any case, 
ratings (or research) should not be used or relied upon as investment 
advice. An investor's decision to buy or sell a stock should depend on 
individual circumstances (such as the investor's existing holdings) and other 
considerations. 
Analyst Stock Ratings 
Outperform: The stock’s total return over the next 12-18 months is 
expected to exceed the return of its relevant broad market benchmark, as 
indicated below.  
Neutral: The stock’s total return over the next 12-18 months is expected to 
be in line with the return of its relevant broad market benchmark, as 
indicated below. For purposes only of FINRA/NYSE ratings distribution 
rules, our Neutral rating falls into a hold rating category. 
Underperform: The stock’s total return over the next 12-18 months is 
expected to be below the return of its relevant broad market benchmark, 
as indicated below. 
Benchmarks for each stock’s listed region are as follows: Japan – TOPIX, 
Korea – KOSPI, Taiwan – TAIEX, India – Nifty100, US – SP500; for all other 
China-concept stocks – MSCI China. 
 
截至2022 年9 月30 日海通国际股票研究评级分布 
 
优于大市 
中性 
弱于大市 
 
 
(持有) 
 
海通国际股票研究覆盖率   
89.4% 
9.2% 
1.4% 
投资银行客户*  
5.5% 
6.8% 
4.5% 
*在每个评级类别里投资银行客户所占的百分比。 
上述分布中的买入，中性和卖出分别对应我们当前优于大市，中性和落后大市评级。 
只有根据FINRA/NYSE 的评级分布规则，我们才将中性评级划入持有这一类别。请注意在上表中不包含非评级的股票。 
此前的评级系统定义（直至2020 年6 月30 日）： 
买入，未来12-18 个月内预期相对基准指数涨幅在10%以上，基准定义如下 
中性，未来12-18 个月内预期相对基准指数变化不大，基准定义如下。根据FINRA/NYSE 的评级分布规则，我们会将中性评级划入持有这一类别。 
卖出，未来12-18 个月内预期相对基准指数跌幅在10%以上，基准定义如下 
各地股票基准指数：日本 – TOPIX, 韩国 – KOSPI, 台湾 – TAIEX, 印度 – Nifty100; 其他所有中国概念股 – MSCI China. 
 
Haitong International Equity Research Ratings Distribution, as of Sep 30, 2022 
 
Outperform 
Neutral 
Underperform 
 
 
(hold) 
 
HTI Equity Research Coverage   
89.4% 
9.2% 
1.4% 
IB clients*  
5.5% 
6.8% 
4.5% 
*Percentage of investment banking clients in each rating category. 
BUY, Neutral, and SELL in the above distribution correspond to our current ratings of Outperform, Neutral, and Underperform. 
For purposes only of FINRA/NYSE ratings distribution rules, our Neutral rating falls into a hold rating category. Please note that stocks with an NR designation are not included in the table above. 
Previous rating system definitions (until 30 Jun 2020): 
BUY: The stock’s total return over the next 12-18 months is expected to exceed the return of its relevant broad market benchmark, as indicated below.  
NEUTRAL: The stock’s total return over the next 12-18 months is expected to be in line with the return of its relevant broad market benchmark, as indicated below. For purposes 
only of FINRA/NYSE ratings distribution rules, our Neutral rating falls into a hold rating category. 
SELL: The stock’s total return over the next 12-18 months is expected to be below the return of its relevant broad market benchmark, as indicated below. 
Benchmarks for each stock’s listed region are as follows: Japan – TOPIX, Korea – KOSPI, Taiwan – TAIEX, India – Nifty100; for all other China-concept stocks – MSCI China. 
 
海通国际非评级研究：海通国际发布计量、筛选或短篇报告，并在报告中根据估值和其他指标对股票进行排名，或者基于可能的估值倍数提出建议价格。这种排名或建议价格并非为
了进行股票评级、提出目标价格或进行基本面估值，而仅供参考使用。 
Haitong International Non-Rated Research:  Haitong International publishes quantitative, screening or short reports which may rank stocks according to valuation and other metrics or may suggest 
prices based on possible valuation multiples. Such rankings or suggested prices do not purport to be stock ratings or target prices or fundamental values and are for information only. 
海通国际A 股覆盖：海通国际可能会就沪港通及深港通的中国A 股进行覆盖及评级。海通证券（600837.CH），海通国际于上海的母公司，也会于中国发布中国A 股的研究报告。但
是，海通国际使用与海通证券不同的评级系统，所以海通国际与海通证券的中国A 股评级可能有所不同。 
 
 
 
 
17 
Haitong International Coverage of A-Shares:  Haitong International may cover and rate A-Shares that are subject to the Hong Kong Stock Connect scheme with Shanghai and Shenzhen. Haitong 
Securities (HS; 600837 CH), the ultimate parent company of HTISG  based in Shanghai, covers and publishes research on these same A-Shares for distribution in mainland China. However, the rating 
system employed by HS differs from that used by HTI and as a result there may be a difference in the HTI and HS ratings for the same A-share stocks. 
海通国际优质100 A 股（Q100）指数：海通国际Q100 指数是一个包括100 支由海通证券覆盖的优质中国A 股的计量产品。这些股票是通过基于质量的筛选过程，并结合对海通证券 A
股团队自下而上的研究。海通国际每季对Q100 指数成分作出复审。 
Haitong International Quality 100 A-share (Q100) Index:  HTI’s Q100 Index is a quant product that consists of 100 of the highest-quality A-shares under coverage at HS in Shanghai. These stocks are 
carefully selected through a quality-based screening process in combination with a review of the HS A-share team’s bottom-up research. The Q100 constituent companies are reviewed quarterly. 
 
MSCI ESG 评级免责声明条款：尽管海通国际的信息供货商（包括但不限于MSCI ESG Research LLC 及其联属公司（「ESG 方」）从其认为可靠的来源获取信息（「信息」）, ESG 方均不
担保或保证此处任何数据的原创性，准确性和/或完整性，并明确表示不作出任何明示或默示的担保，包括可商售性和针对特定目的的适用性。该信息只能供阁下内部使用，不得以任
何形式复制或重新传播，并不得用作任何金融工具、产品或指数的基础或组成部分。此外，信息本质上不能用于判断购买或出售何种证券, 或何时购买或出售该证券。即使已被告知可
能造成的损害, ESG 方均不承担与此处任何资料有关的任何错误或遗漏所引起的任何责任，也不对任何直接、间接、特殊、惩罚性、附带性或任何其他损害赔偿（包括利润损失）承担
任何责任。 
MSCI ESG Disclaimer: Although Haitong International’s information providers, including without limitation, MSCI ESG Research LLC and its affiliates (the “ESG Parties”), obtain information (the 
“Information”) from sources they consider reliable, none of the ESG Parties warrants or guarantees the originality, accuracy and/or completeness, of any data herein and expressly disclaim all express 
or implied warranties, including those of merchantability and fitness for a particular purpose. The Information may only be used for your internal use, may not be reproduced or redisseminated in 
any form and may not be used as a basis for, or a component of, any financial instruments or products or indices. Further, none of the Information can in and of itself be used to determine which 
securities to buy or sell or when to buy or sell them. None of the ESG Parties shall have any liability for any errors or omissions in connection with any data herein, or any liability for any direct, 
indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. 
盟浪义利（FIN-ESG）数据通免责声明条款：在使用盟浪义利（FIN-ESG）数据之前，请务必仔细阅读本条款并同意本声明： 
第一条 义利（FIN-ESG）数据系由盟浪可持续数字科技有限责任公司（以下简称“本公司”）基于合法取得的公开信息评估而成，本公司对信息的准确性及完整性不作任何保证。对公司
的评估结果仅供参考，并不构成对任何个人或机构投资建议，也不能作为任何个人或机构购买、出售或持有相关金融产品的依据。本公司不对任何个人或机构投资者因使用本数据表
述的评估结果造成的任何直接或间接损失负责。  
第二条 盟浪并不因收到此评估数据而将收件人视为客户，收件人使用此数据时应根据自身实际情况作出自我独立判断。本数据所载内容反映的是盟浪在最初发布本数据日期当日的判
断，盟浪有权在不发出通知的情况下更新、修订与发出其他与本数据所载内容不一致或有不同结论的数据。除非另行说明，本数据（如财务业绩数据等）仅代表过往表现，过往的业
绩表现不作为日后回报的预测。  
第三条 本数据版权归本公司所有，本公司依法保留各项权利。未经本公司事先书面许可授权，任何个人或机构不得将本数据中的评估结果用于任何营利性目的，不得对本数据进行修
改、复制、编译、汇编、再次编辑、改编、删减、缩写、节选、发行、出租、展览、表演、放映、广播、信息网络传播、摄制、增加图标及说明等，否则因此给盟浪或其他第三方造
成损失的，由用户承担相应的赔偿责任，盟浪不承担责任。 
第四条 如本免责声明未约定，而盟浪网站平台载明的其他协议内容（如《盟浪网站用户注册协议》《盟浪网用户服务（含认证）协议》《盟浪网隐私政策》等）有约定的，则按其他
协议的约定执行；若本免责声明与其他协议约定存在冲突或不一致的，则以本免责声明约定为准。 
SusallWave FIN-ESG Data Service Disclaimer: Please read these terms and conditions below carefully and confirm your agreement and acceptance with these terms before using SusallWave FIN-
ESG Data Service. 
1. 
FIN-ESG Data is produced by SusallWave Digital Technology Co., Ltd. (In short, SusallWave)’s assessment based on legal publicly accessible information. SusallWave shall not be responsible 
for any accuracy and completeness of the information. The assessment result is for reference only. It is not for any investment advice for any individual or institution and not for basis of purchasing, 
selling or holding any relative financial products. We will not be liable for any direct or indirect loss of any individual or institution as a result of using SusallWave FIN-ESG Data. 
2. 
SusallWave do not consider recipients as customers for receiving these data. When using the data, recipients shall make your own independent judgment according to your practical individual 
status. The contents of the data reflect the judgment of us only on the release day. We have right to update and amend the data and release other data that contains inconsistent contents or 
different conclusions without notification. Unless expressly stated, the data (e.g., financial performance data) represents past performance only and the past performance cannot be viewed as the 
prediction of future return. 
3. 
The copyright of this data belongs to SusallWave, and we reserve all rights in accordance with the law. Without the prior written permission of our company, none of individual or institution 
can use these data for any profitable purpose. Besides, none of individual or institution can take actions such as amendment, replication, translation, compilation, re-editing, adaption, deletion, 
abbreviation, excerpts, issuance, rent, exhibition, performance, projection, broadcast, information network transmission, shooting, adding icons and instructions. If any loss of SusallWave or any 
third-party is caused by those actions, users shall bear the corresponding compensation liability. SusallWave shall not be responsible for any loss. 
4. 
If any term is not contained in this disclaimer but written in other agreements on our website (e.g. User Registration Protocol of SusallWave Website, User Service (including authentication) 
Agreement of SusallWave Website, Privacy Policy of Susallwave Website), it should be executed according to other agreements. If there is any difference between this disclaim and other agreements, 
this disclaimer shall be applied.     
 
重要免责声明： 
非印度证券的研究报告：本报告由海通国际证券集团有限公司（“HTISGL”）的全资附属公司海通国际研究有限公司（“HTIRL”）发行，该公司是根据香港证券及期货条例（第571 章）持
有第4 类受规管活动（就证券提供意见）的持牌法团。该研究报告在HTISGL 的全资附属公司Haitong International (Japan) K.K.（“HTIJKK”）的协助下发行，HTIJKK 是由日本关东财务局监
 
 
 
 
18 
管为投资顾问。 
印度证券的研究报告：本报告由从事证券交易、投资银行及证券分析及受Securities and Exchange Board of India（“SEBI”）监管的Haitong Securities India Private Limited（“HTSIPL”）所发
行，包括制作及发布涵盖BSE Limited（“BSE”）和National Stock Exchange of India Limited（“NSE”）上市公司（统称为「印度交易所」）的研究报告。HTSIPL 于2016 年12 月22 日被收购
并成为海通国际证券集团有限公司（“HTISG”）的一部分。  
所有研究报告均以海通国际为名作为全球品牌，经许可由海通国际证券股份有限公司及/或海通国际证券集团的其他成员在其司法管辖区发布。 
本文件所载信息和观点已被编译或源自可靠来源，但HTIRL、HTISCL 或任何其他属于海通国际证券集团有限公司（“HTISG”）的成员对其准确性、完整性和正确性不做任何明示或暗示的
声明或保证。本文件中所有观点均截至本报告日期，如有更改，恕不另行通知。本文件仅供参考使用。文件中提及的任何公司或其股票的说明并非意图展示完整的内容，本文件并非/
不应被解释为对证券买卖的明示或暗示地出价或征价。在某些司法管辖区，本文件中提及的证券可能无法进行买卖。如果投资产品以投资者本国货币以外的币种进行计价，则汇率变化
可能会对投资产生不利影响。过去的表现并不一定代表将来的结果。某些特定交易，包括设计金融衍生工具的，有产生重大风险的可能性，因此并不适合所有的投资者。您还应认识到
本文件中的建议并非为您量身定制。分析师并未考虑到您自身的财务情况，如您的财务状况和风险偏好。因此您必须自行分析并在适用的情况下咨询自己的法律、税收、会计、金融和
其他方面的专业顾问，以期在投资之前评估该项建议是否适合于您。若由于使用本文件所载的材料而产生任何直接或间接的损失，HTISG 及其董事、雇员或代理人对此均不承担任何责
任。  
除对本文内容承担责任的分析师除外，HTISG 及我们的关联公司、高级管理人员、董事和雇员，均可不时作为主事人就本文件所述的任何证券或衍生品持有长仓或短仓以及进行买卖。
HTISG 的销售员、交易员和其他专业人士均可向HTISG 的相关客户和公司提供与本文件所述意见相反的口头或书面市场评论意见或交易策略。HTISG 可做出与本文件所述建议或意见不
一致的投资决策。但HTIRL 没有义务来确保本文件的收件人了解到该等交易决定、思路或建议。 
请访问海通国际网站 www.equities.htisec.com ，查阅更多有关海通国际为预防和避免利益冲突设立的组织和行政安排的内容信息。 
非美国分析师披露信息：本项研究首页上列明的海通国际分析师并未在FINRA 进行注册或者取得相应的资格，并且不受美国FINRA 有关与本项研究目标公司进行沟通、公开露面和自营
证券交易的第2241 条规则之限制。 
IMPORTANT DISCLAIMER 
For research reports on non-Indian securities: The research report is issued by Haitong International Research Limited (“HTIRL”), a wholly owned subsidiary of Haitong International Securities Group 
Limited (“HTISGL”) and a licensed corporation to carry on Type 4 regulated activity (advising on securities) for the purpose of the Securities and Futures Ordinance (Cap. 571) of Hong Kong, with the 
assistance of Haitong International (Japan) K.K. (“HTIJKK”), a wholly owned subsidiary of HTISGL and which is regulated as an Investment Adviser by the Kanto Finance Bureau of Japan. 
For research reports on Indian securities: The research report is issued by Haitong Securities India Private Limited (“HSIPL”), an Indian company and a Securities and Exchange Board of India (“SEBI”) 
registered Stock Broker, Merchant Banker and Research Analyst that, inter alia, produces and distributes research reports covering listed entities on the BSE Limited (“BSE”) and the National Stock 
Exchange of India Limited (“NSE”) (collectively referred to as “Indian Exchanges”). HSIPL was acquired and became part of the Haitong International Securities Group of Companies (“HTISG”) on 22 
December 2016.  
All the research reports are globally branded under the name Haitong International and approved for distribution by Haitong International Securities Company Limited (“HTISCL”) and/or any other 
members within HTISG in their respective jurisdictions. 
The information and opinions contained in this research report have been compiled or arrived at from sources believed to be reliable and in good faith but no representation or warranty, express or 
implied, is made by HTIRL, HTISCL, HSIPL, HTIJKK or any other members within HTISG from which this research report may be received, as to their accuracy, completeness or correctness. All opinions 
expressed herein are as of the date of this research report and are subject to change without notice. This research report is for information purpose only. Descriptions of any companies or their 
securities mentioned herein are not intended to be complete and this research report is not, and should not be construed expressly or impliedly as, an offer to buy or sell securities. The securities 
referred to in this research report may not be eligible for purchase or sale in some jurisdictions. If an investment product is denominated in a currency other than an investor's home currency, a 
change in exchange rates may adversely affect the investment. Past performance is not necessarily indicative of future results. Certain transactions, including those involving derivatives, give rise to 
substantial risk and are not suitable for all investors. You should also bear in mind that recommendations in this research report are not tailor-made for you. The analyst has not taken into account 
your unique financial circumstances, such as your financial situation and risk appetite. You must, therefore, analyze and should, where applicable, consult your own legal, tax, accounting, financial 
and other professional advisers to evaluate whether the recommendations suits you before investment. Neither HTISG nor any of its directors, employees or agents accepts any liability whatsoever 
for any direct or consequential loss arising from any use of the materials contained in this research report.  
HTISG and our affiliates, officers, directors, and employees, excluding the analysts responsible for the content of this document, will from time to time have long or short positions in, act as principal 
in, and buy or sell, the securities or derivatives, if any, referred to in this research report. Sales, traders, and other professionals of HTISG may provide oral or written market commentary or trading 
strategies to the relevant clients and the companies within HTISG that reflect opinions that are contrary to the opinions expressed in this research report. HTISG may make investment decisions that 
are inconsistent with the recommendations or views expressed in this research report. HTI is under no obligation to ensure that such other trading decisions, ideas or recommendations are brought 
to the attention of any recipient of this research report. 
Please refer to HTI’s website www.equities.htisec.com for further information on HTI’s organizational and administrative arrangements set up for the prevention and avoidance of conflicts of interest 
with respect to Research. 
Non U.S. Analyst Disclosure:  The HTI analyst(s) listed on the cover of this Research is (are) not registered or qualified as a  research analyst with FINRA and are not subject to U.S. FINRA Rule 2241 
restrictions on communications with companies that are the subject of the Research; public appearances; and trading securities by a research analyst. 
分发和地区通知： 
除非下文另有规定，否则任何希望讨论本报告或者就本项研究中讨论的任何证券进行任何交易的收件人均应联系其所在国家或地区的海通国际销售人员。   
香港投资者的通知事项：海通国际证券股份有限公司(“HTISCL”)负责分发该研究报告，HTISCL 是在香港有权实施第1 类受规管活动（从事证券交易）的持牌公司。该研究报告并不构成
《证券及期货条例》（香港法例第571 章）（以下简称“SFO”）所界定的要约邀请，证券要约或公众要约。本研究报告仅提供给SFO 所界定的“专业投资者”。本研究报告未经过证券及
期货事务监察委员会的审查。您不应仅根据本研究报告中所载的信息做出投资决定。本研究报告的收件人就研究报告中产生或与之相关的任何事宜请联系HTISCL 销售人员。 
 
 
 
 
19 
美国投资者的通知事项：本研究报告由HTIRL，HSIPL 或HTIJKK 编写。 HTIRL，HSIPL，HTIJKK 以及任何非HTISG 美国联营公司，均未在美国注册，因此不受美国关于研究报告编制和研
究分析人员独立性规定的约束。本研究报告提供给依照1934 年“美国证券交易法”第15a-6 条规定的豁免注册的「美国主要机构投资者」（“Major U.S. Institutional Investor”）和「机构投
资者」（”U.S. Institutional Investors”）。在向美国机构投资者分发研究报告时，Haitong International Securities (USA) Inc. （“HTI USA”） 将对报告的内容负责。任何收到本研究报告的美国
投资者，希望根据本研究报告提供的信息进行任何证券或相关金融工具买卖的交易，只能通过HTI USA。HTI USA 位于340 Madison Avenue, 12th Floor, New York, NY 10173，电话（212）
351-6050。 HTI USA 是在美国于U.S. Securities and Exchange Commission（“SEC”）注册的经纪商，也是Financial Industry Regulatory Authority, Inc.（“FINRA”）的成员。 HTIUSA 不负责编写
本研究报告，也不负责其中包含的分析。在任何情况下，收到本研究报告的任何美国投资者，不得直接与分析师直接联系，也不得通过HSIPL，HTIRL 或HTIJKK 直接进行买卖证券或相
关金融工具的交易。本研究报告中出现的HSIPL，HTIRL 或HTIJKK 分析师没有注册或具备FINRA 的研究分析师资格，因此可能不受FINRA 第2241 条规定的与目标公司的交流，公开露面
和分析师账户持有的交易证券等限制。投资本研究报告中讨论的任何非美国证券或相关金融工具（包括ADR）可能存在一定风险。非美国发行的证券可能没有注册，或不受美国法规的
约束。有关非美国证券或相关金融工具的信息可能有限制。外国公司可能不受审计和汇报的标准以及与美国境内生效相符的监管要求。本研究报告中以美元以外的其他货币计价的任何
证券或相关金融工具的投资或收益的价值受汇率波动的影响，可能对该等证券或相关金融工具的价值或收入产生正面或负面影响。美国收件人的所有问询请联系： 
 
Haitong International Securities (USA) Inc. 
340 Madison Avenue, 12th Floor 
New York, NY 10173 
联系人电话：(212) 351 6050 
DISTRIBUTION AND REGIONAL NOTICES 
Except as otherwise indicated below, any Recipient wishing to discuss this research report or effect any transaction in any security discussed in HTI’s research should contact the Haitong International 
salesperson in their own country or region.   
Notice to Hong Kong investors: The research report is distributed by Haitong International Securities Company Limited (“HTISCL”), which is a licensed corporation to carry on Type 1 regulated activity 
(dealing in securities) in Hong Kong. This research report does not constitute a solicitation or an offer of securities or an invitation to the public within the meaning of the SFO. This research report 
is only to be circulated to "Professional Investors" as defined in the SFO. This research report has not been reviewed by the Securities and Futures Commission. You should not make investment 
decisions solely on the basis of the information contained in this research report. Recipients of this research report are to contact HTISCL salespersons in respect of any matters arising from, or in 
connection with, the research report. 
Notice to U.S. investors: As described above, this research report was prepared by HTIRL, HSIPL or HTIJKK. Neither HTIRL, HSIPL, HTIJKK, nor any of the non U.S. HTISG affiliates is registered in the 
United States and, therefore, is not subject to U.S. rules regarding the preparation of research reports and the independence of research analysts.  This research report is provided for distribution to 
“major U.S. institutional investors” and “U.S. institutional investors” in reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended. 
When distributing research reports to “U.S. institutional investors,” HTI USA will accept the responsibilities for the content of the reports.  Any U.S. recipient of this research report wishing to effect 
any transaction to buy or sell securities or related financial instruments based on the information provided in this research report should do so only through Haitong International Securities (USA) 
Inc. (“HTI USA”), located at 340 Madison Avenue, 12th Floor, New York, NY 10173, USA; telephone (212) 351 6050.  HTI USA is a broker-dealer registered in the U.S. with the U.S. Securities and 
Exchange Commission (the “SEC”) and a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”).  HTI USA is not responsible for the preparation of this research report nor for the 
analysis contained therein.  Under no circumstances should any U.S. recipient of this research report contact the analyst directly or effect any transaction to buy or sell securities or related financial 
instruments directly through HSIPL, HTIRL or HTIJKK.  The HSIPL, HTIRL or HTIJKK analyst(s) whose name appears in this research report is not registered or qualified as a research analyst with FINRA 
and, therefore, may not be subject to FINRA Rule 2241 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.  Investing 
in any non-U.S. securities or related financial instruments (including ADRs) discussed in this research report may present certain risks.  The securities of non-U.S. issuers may not be registered with, 
or be subject to U.S. regulations.  Information on such non-U.S. securities or related financial instruments may be limited. Foreign companies may not be subject to audit and reporting standards 
and regulatory requirements comparable to those in effect within the U.S.  The value of any investment or income from any securities or related financial instruments discussed in this research 
report denominated in a currency other than U.S. dollars is subject to exchange rate fluctuations that may have a positive or adverse effect on the value of or income from such securities or related 
financial instruments. All inquiries by U.S. recipients should be directed to: 
Haitong International Securities (USA) Inc. 
340 Madison Avenue, 12th Floor 
New York, NY 10173 
Attn:  Sales Desk at (212) 351 6050 
中华人民共和国的通知事项：在中华人民共和国（下称“中国”，就本报告目的而言，不包括香港特别行政区、澳门特别行政区和台湾）只有根据适用的中国法律法规而收到该材料的人
员方可使用该材料。并且根据相关法律法规，该材料中的信息并不构成“在中国从事生产、经营活动”。本文件在中国并不构成相关证券的公共发售或认购。无论根据法律规定或其他任
何规定，在取得中国政府所有的批准或许可之前，任何法人或自然人均不得直接或间接地购买本材料中的任何证券或任何实益权益。接收本文件的人员须遵守上述限制性规定。 
加拿大投资者的通知事项：在任何情况下该等材料均不得被解释为在任何加拿大的司法管辖区内出售证券的要约或认购证券的要约邀请。本材料中所述证券在加拿大的任何要约或出
售行为均只能在豁免向有关加拿大证券监管机构提交招股说明书的前提下由Haitong International Securities (USA) Inc. （“HTI USA”）予以实施，该公司是一家根据National Instrument 31-
103 Registration Requirements, Exemptions and Ongoing Registrant Obligations（“NI 31-103”）的规定得到「国际交易商豁免」（“International Dealer Exemption” ）的交易商，位于艾伯塔
省、不列颠哥伦比亚省、安大略省和魁北克省。在加拿大，该等材料在任何情况下均不得被解释为任何证券的招股说明书、发行备忘录、广告或公开发行。加拿大的任何证券委员会或
类似的监管机构均未审查或以任何方式批准该等材料、其中所载的信息或所述证券的优点，任何与此相反的声明即属违法。在收到该等材料时，每个加拿大的收件人均将被视为属于
National Instrument 45-106 Prospectus Exemptions 第1.1 节或者Securities Act (Ontario)第73.3(1)节所规定的「认可投资者」（“Accredited Investor”），或者在适用情况下National 
Instrument 31-103 第1.1 节所规定的「许可投资者」（“Permitted Investor”）。 
新加坡投资者的通知事项：本研究报告由Haitong International Securities (Singapore) Pte Ltd（“HTISSPL”）[公司注册编号201311400G] 于新加坡提供。HTISSPL 是符合《财务顾问法》（第
110 章）（“FAA”）定义的豁免财务顾问，可（a）提供关于证券，集体投资计划的部分，交易所衍生品合约和场外衍生品合约的建议（b）发行或公布有关证券、交易所衍生品合约和
 
 
 
 
20 
场外衍生品合约的研究分析或研究报告。本研究报告仅提供给符合《证券及期货法》（第289 章）第4A 条项下规定的机构投资者。对于因本研究报告而产生的或与之相关的任何问
题，本研究报告的收件人应通过以下信息与HTISSPL 联系： 
Haitong International Securities (Singapore) Pte. Ltd 
50 Raffles Place, #33-03 Singapore Land Tower, Singapore 048623 
电话: (65) 6536 1920 
日本投资者的通知事项：本研究报告由海通国际证券有限公司所发布，旨在分发给从事投资管理的金融服务提供商或注册金融机构（根据日本金融机构和交易法（“FIEL”））第61
（1）条，第17-11（1）条的执行及相关条款）。 
英国及欧盟投资者的通知事项：本报告由从事投资顾问的Haitong International Securities Company Limited 所发布，本报告只面向有投资相关经验的专业客户发布。任何投资或与本报告
相关的投资行为只面对此类专业客户。没有投资经验或相关投资经验的客户不得依赖本报告。Haitong International Securities Company Limited 的分支机构的净长期或短期金融权益可能
超过本研究报告中提及的实体已发行股本总额的0.5％。特别提醒有些英文报告有可能此前已经通过中文或其它语言完成发布。 
澳大利亚投资者的通知事项：Haitong International Securities (Singapore) Pte Ltd, Haitong International Securities Company Limited 和Haitong International Securities (UK) Limited 分别根据澳
大利亚证券和投资委员会（以下简称“ASIC”）公司（废除及过度性）文书第2016/396 号规章在澳大利亚分发本项研究，该等规章免除了根据2001 年《公司法》在澳大利亚为批发客户
提供金融服务时海通国际需持有澳大利亚金融服务许可的要求。ASIC 的规章副本可在以下网站获取：www.legislation.gov.au。海通国际提供的金融服务受外国法律法规规定的管制，该
等法律与在澳大利亚所适用的法律存在差异。 
印度投资者的通知事项：本报告由从事证券交易、投资银行及证券分析及受Securities and Exchange Board of India（“SEBI”）监管的Haitong Securities India Private Limited（“HTSIPL”）所
发布，包括制作及发布涵盖BSE Limited（“BSE”）和National Stock Exchange of India Limited（“NSE”）（统称为「印度交易所」）研究报告。 
本项研究仅供收件人使用，未经海通国际的书面同意不得予以复制和再次分发。 
版权所有：海通国际证券集团有限公司2019 年。保留所有权利。 
People’s Republic of China (PRC): In the PRC, the research report is directed for the sole use of those who receive the research report in accordance with the applicable PRC laws and regulations. 
Further, the information on the research report does not constitute "production and business activities in the PRC" under relevant PRC laws. This research report does not constitute a public offer 
of the security, whether by sale or subscription, in the PRC. Further, no legal or natural persons of the PRC may directly or indirectly purchase any of the security or any beneficial interest therein 
without obtaining all prior PRC government approvals or licenses that are required, whether statutorily or otherwise. Persons who come into possession of this research are required to observe 
these restrictions. 
Notice to Canadian Investors: Under no circumstances is this research report to be construed as an offer to sell securities or as a solicitation of an offer to buy securities in any jurisdiction of Canada. 
Any offer or sale of the securities described herein in Canada will be made only under an exemption from the requirements to file a prospectus with the relevant Canadian securities regulators and 
only by Haitong International Securities (USA) Inc., a dealer relying on the “international dealer exemption” under National Instrument 31-103 Registration Requirements, Exemptions and Ongoing 
Registrant Obligations (“NI 31-103”) in Alberta, British Columbia, Ontario and Quebec. This research report is not, and under no circumstances should be construed as, a prospectus, an offering 
memorandum, an advertisement or a public offering of any securities in Canada. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon this 
research report, the information contained herein or the merits of the securities described herein and any representation to the contrary is an offence. Upon receipt of this research report, each 
Canadian recipient will be deemed to have represented that the investor is an “accredited investor” as such term is defined in section 1.1 of National Instrument 45-106 Prospectus Exemptions or, 
in Ontario, in section 73.3(1) of the Securities Act (Ontario), as applicable, and a “permitted client” as such term is defined in section 1.1 of NI 31-103, respectively. 
Notice to Singapore investors: This research report is provided in Singapore by or through Haitong International Securities (Singapore) Pte Ltd (“HTISSPL”) [Co Reg No 201311400G. HTISSPL is an 
Exempt Financial Adviser under the Financial Advisers Act (Cap. 110) (“FAA”) to (a) advise on securities, units in a collective investment scheme, exchange-traded derivatives contracts and over-the-
counter derivatives contracts and (b) issue or promulgate research analyses or research reports on securities, exchange-traded derivatives contracts and over-the-counter derivatives contracts. This 
research report is only provided to institutional investors, within the meaning of Section 4A of the Securities and Futures Act (Cap. 289). Recipients of this research report are to contact HTISSPL via 
the details below in respect of any matters arising from, or in connection with, the research report: 
Haitong International Securities (Singapore) Pte. Ltd. 
10 Collyer Quay, #19-01 - #19-05 Ocean Financial Centre, Singapore 049315 
Telephone: (65) 6536 1920 
Notice to Japanese investors: This research report is distributed by Haitong International Securities Company Limited and intended to be distributed to Financial Services Providers or Registered 
Financial Institutions engaged in investment management (as defined in the Japan Financial Instruments and Exchange Act ("FIEL") Art. 61(1), Order for Enforcement of FIEL Art. 17-11(1), and related 
articles). 
Notice to UK and European Union investors: This research report is distributed by Haitong International Securities Company Limited. This research is directed at persons having professional 
experience in matters relating to investments. Any investment or investment activity to which this research relates is available only to such persons or will be engaged in only with such persons. 
Persons who do not have professional experience in matters relating to investments should not rely on this research.  Haitong International Securities Company Limited’s affiliates may have a net 
long or short financial interest in excess of 0.5% of the total issued share capital of the entities mentioned in this research report.  Please be aware that any report in English may have been published 
previously in Chinese or another language. 
Notice to Australian investors: The research report is distributed in Australia by Haitong International Securities (Singapore) Pte Ltd, Haitong International Securities Company Limited, and Haitong 
International Securities (UK) Limited in reliance on ASIC Corporations (Repeal and Transitional) Instrument 2016/396, which exempts those HTISG entities from the requirement to hold an Australian 
financial services license under the Corporations Act 2001 in respect of the financial services it provides to wholesale clients in Australia.  A copy of the ASIC Class Orders may be obtained at the 
following website, www.legislation.gov.au.  Financial services provided by Haitong International Securities (Singapore) Pte Ltd, Haitong International Securities Company Limited, and Haitong 
 
 
 
 
21 
International Securities (UK) Limited are regulated under foreign laws and regulatory requirements, which are different from the laws applying in Australia. 
Notice to Indian investors: The research report is distributed by Haitong Securities India Private Limited (“HSIPL”), an Indian company and a Securities and Exchange Board of India (“SEBI”) registered 
Stock Broker, Merchant Banker and Research Analyst that, inter alia, produces and distributes research reports covering listed entities on the BSE Limited (“BSE”) and the National Stock Exchange of 
India Limited (“NSE”) (collectively referred to as “Indian Exchanges”).   
This research report is intended for the recipients only and may not be reproduced or redistributed without the written consent of an authorized signatory of HTISG. 
Copyright: Haitong International Securities Group Limited 2019. All rights reserved. 
http://equities.htisec.com/x/legal.html 
 
 
 
